Cargando…
Battling COVID-19: using old weapons for a new enemy
Coronavirus disease-19 (COVID-19) has reached pandemic proportions. Most of the drugs that are being tried for the treatment have not been evaluated in any randomized controlled trials. The purpose of this review was to summarize the in-vitro and in-vivo efficacy of these drugs on Severe Acute Respi...
Autores principales: | Kumar, Rohit, Gupta, Nitin, Kodan, Parul, Mittal, Ankit, Soneja, Manish, Wig, Naveet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237624/ https://www.ncbi.nlm.nih.gov/pubmed/32454984 http://dx.doi.org/10.1186/s40794-020-00107-1 |
Ejemplares similares
-
Is there antibody-dependent enhancement in SARS Coronavirus 2?
por: Kumar, Rohit, et al.
Publicado: (2020) -
Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
por: Gupta, Nitin, et al.
Publicado: (2020) -
Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020) -
Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India
por: Gupta, Nitin, et al.
Publicado: (2020) -
Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient
por: Soneja, Manish, et al.
Publicado: (2021)